Musculoskeletal complications of diabetes post COVID-19
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20215008Keywords:
COVID-19, Diabetes mellitus, Musculoskeletal complications, Myalgia, ArthralgiaAbstract
Background: COVID-19 is an emerging disease caused by the severe respiratory syndrome. This affects the respiratory system but directly or indirectly affects the multiple organ system, including the musculoskeletal system. The patients with diabetes who get COVID are at risk of a severe disease course and mortality.
Methods: The study design is Observational study. The study will be conducted on 30patients who have recovered from covid-19 with diabetes mellitus. The samples of the study are selected randomly. The data will be collected in a non-homogenous way, especially regarding lifestyle habits, and severity of the illness. Myalgia was calculated by numerical rating scale, Arthralgia was calculated by visual analog scale, and fatigue was calculated by Chalder fatigue scale to assess the severity of fatigue.
Results: The severity of the complication was decreased in patients with second month COVID-19 recovery than in the first month.
Conclusions:Background: COVID-19 is an emerging disease caused by the severe respiratory syndrome. This affects the respiratory system but directly or indirectly affects the multiple organ system, including the musculoskeletal system. The patients with diabetes who get COVID are at risk of a severe disease course and mortality.
Methods: The study design is Observational study. The study will be conducted on 30patients who have recovered from covid-19 with diabetes mellitus. The samples of the study are selected randomly. The data will be collected in a non-homogenous way, especially regarding lifestyle habits, and severity of the illness. Myalgia was calculated by numerical rating scale, Arthralgia was calculated by visual analog scale, and fatigue was calculated by Chalder fatigue scale to assess the severity of fatigue.
Results: The severity of the complication was decreased in patients with second month COVID-19 recovery than in the first month.
Conclusions: This study concluded that there is decrease in the severity of musculoskeletal complications in diabetic patients from 1st month to 2nd month COVID-19 recoveries.References
Gupta R, Hussain A, Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr. 2020;74(6):864-70.
Cron RQ, Chatham WW. The rheumatologist’s role in COVID-19. Clin Med. 2020;20(2):124.
Gupta R, Pal SK, Pandey G. A comprehensive analysis of COVID-19 outbreak situation in India. MedRxiv. 2020.
Barker-Davies RM, O’Sullivan O, Senaratne KP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59.
Casella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Stat Pearls. 2021.
Ramani SL, Samet J, Franz CK, Hsieh C, Nguyen CV, Horbinski C, Deshmukh S. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;5:1.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3.
Iacobellis G. COVID-19 and diabetes: can DPP4 inhibition play a role?. Diabetes Res Clin Prac. 2020;162.
Antonelli A, Elia G, Ferrari SM, Foddis R, De Marco S, Cristaudo A, et al. The COVID-19, epidemiology, clinic and prevention. Curr Genom. 2020;21(3):157.
Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278.
Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med. 2020;20(2):124.
Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14(4):3822-35.
Repici A, Aragona G, Cengia G, Cantù P, Spadaccini M, Maselli R, et al. Low risk of covid-19 transmission in GI endoscopy. Gut. 2020;69(11):1925-7.
Jordan RE, Adab P, Cheng K. Covid-19: risk factors for severe disease and death. Curr Genom. 2020;12(5):110.
American diabetes association. Diagnosis and classification of diabetes mellitus. Diab Care. 2014;37(1):S81-90.
Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Canad J Diab. 2018;42:S10-5.
Ramani SL, Samet J, Franz CK, Hsieh C, Nguyen CV, Horbinski C, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;18:1.
Giorgino F, Bhana S, Czupryniak L, Dagdelen S, Galstyan GR, Janež A, et al. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. Diab Res Clin Pract. 2021;5:172.
Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna VE, et al. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol. 2020;11:687.
Vaishya R, Jain VK, Iyengar KP. Musculoskeletal manifestations of COVID-19. J Clin Orthopaed Trauma. 2021.
Kucuk A, Cumhur Cure M, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol. 2020;39:2103-4.
Hoong CW, Amin MN, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021;104:363-9.
Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post-covid-19 fatigue: Potential contributing factors. Brain Sci. 2020;10(12):1012.